Suppr超能文献

神经调节蛋白-1/表皮生长因子受体(ErbB)信号传导:治疗心力衰竭的可药物作用靶点。

Neuregulin-1/ErbB signaling: a druggable target for treating heart failure.

作者信息

Xu Yabei, Li Xinyan, Zhou Mingdong

机构信息

Zensun (Shanghai) Science and Technology Co. Ltd, 328 Bi Bo Road, Zhangjiang Hi-tech Park, Shanghai, PR China.

出版信息

Curr Opin Pharmacol. 2009 Apr;9(2):214-9. doi: 10.1016/j.coph.2008.11.004. Epub 2008 Dec 11.

Abstract

Neuregulin-1s are widely expressed signaling molecules that are involved in cell differentiation, proliferation, growth, survival, and apoptosis. They transmit their signals by interacting with cell membrane receptors of the ErbB family, resulting in the activation of intracellular signaling cascades, which participate in various physiological and etiological processes. Besides their essential function in the development of the heart and the physiology of cardiac pumping, there is emerging evidence for the involvement of neuregulin-1/ErbB signals in human disease, including heart failure. These reasons prompt the development of new therapeutic agents based on neuregulin-1.

摘要

神经调节蛋白-1是广泛表达的信号分子,参与细胞分化、增殖、生长、存活和凋亡。它们通过与ErbB家族的细胞膜受体相互作用来传递信号,从而激活细胞内信号级联反应,这些反应参与各种生理和病因学过程。除了在心脏发育和心脏泵血生理过程中的重要作用外,越来越多的证据表明神经调节蛋白-1/ErbB信号参与人类疾病,包括心力衰竭。这些原因促使人们开发基于神经调节蛋白-1的新型治疗药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验